A retrospective study assessing the efficacy and safety of the long-term use of nimotuzumab in combination with intensity-modulated radiotherapy (IMRT) and chemotherapy in the treatment of advanced nasopharyngeal carcinoma
Latest Information Update: 11 Sep 2018
At a glance
- Drugs Nimotuzumab (Primary) ; Cisplatin; Docetaxel; Fluorouracil; Gemcitabine
- Indications Carcinoma; Nasopharyngeal cancer
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 11 Sep 2018 New trial record